Sabahat Bokhari, a Rutgers professor of medicine and an amyloidosis expert, will direct a fellowship at Robert Wood Johnson University Hospital
Inventions & Commercialization
Driving a Culture of Innovation and Entrepreneurship at Rutgers through technology transfer.
Available Technologies
Looking for an invention or technology to commercialize? Explore our portfolio of technologies available for licensing.
Email us at marketingbd@research.rutgers.edu for questions and partnership opportunities.
What We Do
Staffed by scientists and IP experts with industry experience, the Office for Research is dedicated to transforming research at Rutgers into products, services, and partnerships for the public good, generating value for the University and New Jersey. We do this through technology transfer, guiding your research from proof of concept through patenting, licensing, and commercialization, while also evaluating the potential for a startup as a vehicle to bring your innovations to the market. If a startup option is selected, we will assist you with the planning and development that lead to a spin-out of your innovation. We will also provide mentoring, access to early-stage seed funding, support in obtaining dilutive/non-dilutive funding, assistance with product and business development, and connection to industry and potential business founders.
Account Access
To access your account, please select the appropriate option below.
From Ideas to Impact
Tech Transfer's purpose is to partner with the Rutgers community to encourage deliberate innovation, protect and leverage Rutgers intellectual property, foster collaboration with industry, and enable entrepreneurship.
160
Global Patents Issued
Fiscal Year 2023
102
Active Startups
Fiscal Year 2023
$12.7 Million
in Licensing Revenue
Fiscal Year 2023
160
Invention Disclosures
Fiscal Year 2023
Research and Innovation News
Enver Cagri Izgu, PhD, from the School of Arts and Sciences at Rutgers-New Brunswick, and his team will use a nearly $2 million NIH grant to develop diverse molecules with “programmed functionality” to address the fundamental challenges in therapeutic approaches that rely on modulating gene expression.
Rutgers Health research reveals how dental check-ups could be the first line of defense against deadly sleep disorders.
Nosker has been named a 2024 National Academy of Inventors (NAI) Fellow, the highest professional distinction awarded to academic inventors.
A catalyst that converts waste CO₂ to chemical products. A monoclonal antibody that could revolutionize the detection of tuberculosis. Both innovations were developed at Rutgers, The State University of New Jersey, and both received 2024 Edison Patent Awards at the annual Research & Development (R&D) Council of New Jersey (RDNJ) banquet.